"RNA, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
RNA present in neoplastic tissue.
| Descriptor ID |
D012334
|
| MeSH Number(s) |
D13.444.735.615
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "RNA, Neoplasm".
Below are MeSH descriptors whose meaning is more specific than "RNA, Neoplasm".
This graph shows the total number of publications written about "RNA, Neoplasm" by people in this website by year, and whether "RNA, Neoplasm" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2017 | 7 | 6 | 13 |
| 2018 | 9 | 3 | 12 |
| 2019 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "RNA, Neoplasm" by people in Profiles.
-
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence. Sci Rep. 2019 10 16; 9(1):14863.
-
Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Res. 2019 Oct 15; 79(20):5131-5139.
-
MALAT1 rs664589 Polymorphism Inhibits Binding to miR-194-5p, Contributing to Colorectal Cancer Risk, Growth, and Metastasis. Cancer Res. 2019 10 15; 79(20):5432-5441.
-
Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma. J Cell Biochem. 2019 08; 120(8):13751-13764.
-
Endothelial miR-30c suppresses tumor growth via inhibition of TGF-Ă-induced Serpine1. J Clin Invest. 2019 03 11; 129(4):1654-1670.
-
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma. J Clin Invest. 2018 12 03; 128(12):5505-5516.
-
Sertad1 promotes prostate cancer progression through binding androgen receptor ligand binding domain. Int J Cancer. 2019 02 01; 144(3):558-568.
-
miR-135a-5p Functions as a Glioma Proliferation Suppressor by Targeting Tumor Necrosis Factor Receptor-Associated Factor 5 and Predicts Patients' Prognosis. Am J Pathol. 2019 01; 189(1):162-176.
-
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci Rep. 2018 08 30; 8(1):13106.
-
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018 09; 19(9):1180-1191.